SUMO-1 CRISPR Knockout and Activation Products (h)

Por um escritor misterioso

Last updated 20 setembro 2024

SUMO-1 CRISPR Knockout and Activation Products (h)

SUMO-1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human SUMO-1 gene expression

SUMO-4 CRISPR Knockout and Activation Products (h)

SUMO-1 CRISPR Knockout and Activation Products (h)

SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation

FAT10 inhibits SUMO activation by AOS1/UBA2. a In vitro

Biomolecules, Free Full-Text

Chemogenetic System Demonstrates That Cas9 Longevity Impacts Genome Editing Outcomes

Interferon, restriction factors and SUMO pathways - ScienceDirect

SUMO-4 CRISPR Knockout and Activation Products (h)

CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations - ScienceDirect

Native Semisynthesis of Isopeptide-Linked Substrates for Specificity Analysis of Deubiquitinases and Ubl Proteases

Alternative splicing of the SUMO1/2/3 transcripts affects cellular SUMOylation and produces functionally distinct SUMO protein isoforms

Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility

Exo1-protected DNA nicks direct crossover formation in meiosis

Genome Engineering: Genome Editing with CRISPR-Cas9 Leaders in Pharmaceutical Business Intelligence (LPBI) Group

IJMS, Free Full-Text

Recomendado para você